RGNX – REGENXBIO Inc.
RGNX — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
14.08
Margin Of Safety %
Put/Call OI Ratio
0.56
EPS Next Q Diff
1.4
EPS Last/This Y
1.76
EPS This/Next Y
-0.2
Price
8.79
Target Price
29.25
Analyst Recom
1.42
Performance Q
-34.33
Upside
-654.0%
Beta
1.15
Ticker: RGNX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | RGNX | 10.36 | 0.44 | 0.08 | 8391 |
| 2026-03-10 | RGNX | 9.91 | 0.43 | 0.02 | 8701 |
| 2026-03-11 | RGNX | 9.36 | 0.42 | 6.35 | 8736 |
| 2026-03-12 | RGNX | 9.1 | 0.48 | 0.06 | 9065 |
| 2026-03-13 | RGNX | 9.08 | 0.48 | 0.09 | 9065 |
| 2026-03-17 | RGNX | 8.64 | 0.49 | 0.05 | 9247 |
| 2026-03-18 | RGNX | 8.29 | 0.48 | 0.05 | 9404 |
| 2026-03-19 | RGNX | 8.36 | 0.48 | 0.20 | 9445 |
| 2026-03-20 | RGNX | 8.12 | 0.48 | 0.49 | 9445 |
| 2026-03-23 | RGNX | 8.34 | 0.50 | 0.34 | 7444 |
| 2026-03-24 | RGNX | 7.81 | 0.50 | 0.16 | 7620 |
| 2026-03-25 | RGNX | 8.44 | 0.49 | 2.92 | 7786 |
| 2026-03-26 | RGNX | 8.27 | 0.53 | 2.54 | 8159 |
| 2026-03-27 | RGNX | 7.76 | 0.53 | 10.00 | 8195 |
| 2026-03-30 | RGNX | 7.76 | 0.55 | 0.85 | 8264 |
| 2026-03-31 | RGNX | 8.38 | 0.55 | 0.00 | 8279 |
| 2026-04-01 | RGNX | 8.62 | 0.55 | 0.06 | 8296 |
| 2026-04-02 | RGNX | 8.52 | 0.53 | 4.50 | 8465 |
| 2026-04-06 | RGNX | 8.79 | 0.54 | 1.12 | 8496 |
| 2026-04-07 | RGNX | 8.79 | 0.56 | 2.36 | 8962 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | RGNX | 10.36 | -1336.1 | 279.6 | -1.04 |
| 2026-03-10 | RGNX | 9.91 | -1336.1 | 269.7 | -1.04 |
| 2026-03-11 | RGNX | 9.36 | -1336.1 | 257.7 | -1.04 |
| 2026-03-12 | RGNX | 9.08 | -1336.1 | 251.0 | -1.04 |
| 2026-03-13 | RGNX | 8.56 | -1280.0 | 239.5 | -2.00 |
| 2026-03-17 | RGNX | 8.64 | -1280.0 | 206.8 | -2.00 |
| 2026-03-18 | RGNX | 8.29 | -1280.0 | 203.2 | -2.00 |
| 2026-03-19 | RGNX | 8.36 | -1280.0 | 204.1 | -2.00 |
| 2026-03-20 | RGNX | 8.10 | -1280.0 | 201.3 | -2.00 |
| 2026-03-23 | RGNX | 8.33 | -1280.0 | 203.8 | -2.00 |
| 2026-03-24 | RGNX | 7.81 | -1280.0 | 198.3 | -2.00 |
| 2026-03-25 | RGNX | 8.44 | -1280.0 | 204.9 | -2.00 |
| 2026-03-26 | RGNX | 8.27 | -1280.0 | 203.0 | -2.00 |
| 2026-03-27 | RGNX | 7.76 | -1280.0 | 197.8 | -2.00 |
| 2026-03-30 | RGNX | 7.76 | -1278.3 | 197.8 | -2.00 |
| 2026-03-31 | RGNX | 8.37 | -1278.3 | 204.0 | -2.00 |
| 2026-04-01 | RGNX | 8.62 | -1278.3 | 206.7 | -2.00 |
| 2026-04-02 | RGNX | 8.52 | -1278.3 | 205.6 | -2.00 |
| 2026-04-06 | RGNX | 8.80 | -1278.3 | 208.6 | -2.00 |
| 2026-04-07 | RGNX | 8.79 | -1278.3 | 205.7 | -2.00 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | RGNX | -0.63 | 0.25 | 13.05 |
| 2026-03-10 | RGNX | -0.63 | 0.25 | 13.05 |
| 2026-03-11 | RGNX | -0.63 | 0.25 | 13.90 |
| 2026-03-12 | RGNX | -0.63 | 0.25 | 13.90 |
| 2026-03-13 | RGNX | -0.59 | 0.25 | 13.90 |
| 2026-03-17 | RGNX | -0.59 | 0.24 | 13.90 |
| 2026-03-18 | RGNX | -0.59 | 0.24 | 13.90 |
| 2026-03-19 | RGNX | -0.59 | 0.24 | 13.90 |
| 2026-03-20 | RGNX | -0.59 | 0.24 | 13.90 |
| 2026-03-23 | RGNX | -0.59 | 0.24 | 13.90 |
| 2026-03-24 | RGNX | -0.59 | 0.24 | 13.90 |
| 2026-03-25 | RGNX | -0.59 | 0.24 | 14.08 |
| 2026-03-26 | RGNX | -0.59 | 0.24 | 14.08 |
| 2026-03-27 | RGNX | -0.59 | 0.24 | 14.08 |
| 2026-03-30 | RGNX | -0.59 | 0.24 | 14.08 |
| 2026-03-31 | RGNX | -0.59 | 0.24 | 14.08 |
| 2026-04-01 | RGNX | -0.59 | 0.24 | 14.08 |
| 2026-04-02 | RGNX | -0.46 | 0.24 | 14.08 |
| 2026-04-06 | RGNX | -0.46 | 0.24 | 14.08 |
| 2026-04-07 | RGNX | -0.46 | 0.24 | 14.08 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.3
Avg. EPS Est. Current Quarter
-1.41
Avg. EPS Est. Next Quarter
0.1
Insider Transactions
-0.46
Institutional Transactions
0.24
Beta
1.15
Average Sales Estimate Current Quarter
25
Average Sales Estimate Next Quarter
111
Fair Value
Quality Score
40
Growth Score
40
Sentiment Score
87
Actual DrawDown %
81.1
Max Drawdown 5-Year %
-88.4
Target Price
29.25
P/E
Forward P/E
PEG
P/S
2.66
P/B
4.36
P/Free Cash Flow
EPS
-3.75
Average EPS Est. Cur. Y
-2
EPS Next Y. (Est.)
-2.2
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-113.75
Relative Volume
0.5
Return on Equity vs Sector %
-216.2
Return on Equity vs Industry %
-199.6
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.18
EBIT Estimation
205.7
◆
RGNX
Healthcare
$8.80
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
50.7
Range 1M
38.6%
Sup Dist
3.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
42.8%
EPS NY
-30.5%
52W%
33.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+232.4% upside
Upside
+232.4%
Quality
40
REGENXBIO Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 371
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
RGNX
Latest News
—
Caricamento notizie per RGNX…
stock quote shares RGNX – REGENXBIO Inc. Stock Price stock today
news today RGNX – REGENXBIO Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RGNX – REGENXBIO Inc. yahoo finance google finance
stock history RGNX – REGENXBIO Inc. invest stock market
stock prices RGNX premarket after hours
ticker RGNX fair value insiders trading